Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Incomplete HIV-1 antibody evolution and sero-reversion in acutely infected individuals treated with early antiretroviral therapy

Incomplete HIV-1 antibody evolution and sero-reversion in acutely infected individuals treated with early antiretroviral therapy. Clinical Infectious Diseases. 2005; 40(6):868-73.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.